版本:
中国

BRIEF-X-Chem and Vertex enter into multi-target genetic disease collaboration

May 16 Vertex Pharmaceuticals Inc

* X-Chem and Vertex enter into multi-target genetic disease collaboration

* X-Chem - Vertex will have the option to license lead-like hits discovered under the collaboration

* X-Chem - Vertex will be responsible for further development and commercialization of the resulting programs

* X-Chem - will receive an upfront payment and potential research, development and regulatory milestones and licensing fees Source text for Eikon: (bit.ly/2qrFISY) Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐